Kerala Ayurveda Ltd — Updates, 27-05-2025: Company Update

Kerala Ayurveda Ltd reported a 22% rise in consolidated revenue to Rs. 137.2 Cr in FY25, driven by strong growth in the US business (51%), India Ecommerce (21%), and health services (22%). Adjusted EBITDA was positive at Rs. 3.1 Cr despite heavy investments in marketing, talent (Rs. 13.5 Cr), technology, and infrastructure (Rs. 6 Cr). PAT was a loss of Rs. 13.95 Cr due to these growth investments and first-time ESOP provisioning (Rs. 6.2 Cr). The company aims to double growth to 50% in FY26, supported by digital expansion, new premium products, clinic upgrades, and international partnerships, positioning itself as a global Ayurveda leader.